GolperT.A.: Drugs and peritoneal dialysis.Dial. and Transpl.,8, 41, 1979.
4.
GibsonT.P.: Dialyzability of common therapeutic agents.Dial. and Transpl.,8, 24, 1979.
5.
BarzaM., WeisteinL.: Pharmacokinetics of the penicillins in man.Clin. Pharmacokin.,1, 297, 1976.
6.
RuedyJ.: The effects of peritoneal dialysis on the physiological disposition of oxacillin, ampicillin and tetracycline in patients with renal disease.Can. Med. Ass. J.,94, 257, 1966.
7.
BulgerR.J., BennetJ.V., BoenS.T.: Intraperitoneal administration of broad-spectrum antibiotics in patients with renal failure.JAMA,194, 140, 1965.
8.
NormannE., AuneS.: Absorption of ampicillin from peritoneal cavity.Arch. Surg.,102, 469, 1971.
9.
AndersonR.J., BennetW.M., GambertoglioJ.G., SchrierR.W.: Fate of drugs in renal failure. In: The Kidney, Edit. by BrennerB.M., RectorF.C.Jr.., Philadelphia, WB Saunders Co.,2659, 2708, 1981.
10.
BuckA.C., CohenS.L.: Absorption of antibiotics during peritoneal dialysis in patients with renal failure.J. Clin. Path., 21, 88, 1968.
11.
OeF.L., SimonianS., VerhoefJ.: Pharmacokinetics of the new penicillins: amoxycillin and flucloxacillin in patients with terminal renal failure undergoing hemodialysis.Chemotherapy,19, 279, 1973.
12.
EastwoodJ.B., CurtisJ.R.: Carbenicillin administration in patients with severe renal failure.Br. Med. J.,1, 486, 1968.
13.
WiseR., ReevesD.S., ParkerA.S.: Administration of ticarcillin, a new antipseudomonal antibiotic, in patients undergoing dialysis.Antimicrob. Ag. Chemother.,5, 119, 1974.
14.
FranckeE.L., AppelG.B., NeuH.C.: Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.Antimicrobial Agents and Chemoth., 788, 1979.
CurtisJ.R., MarshallM.J.: Cephaloridine serum levels in patients on maintenance hemodilysis.Br. Med. J.,2, 149, 1970.
17.
PerkinsR.L., SmithE.M., SaslowS.: Cephalotin and cephaloridin: comparative pharmacodynamics in chronic uremia.Am. J. Med. Sci.,257, 116, 1969.
18.
KabinsS.A., KelnerB., WaltonE.: Cephalexin therapy as related to renal function.Am. J. Med. Sci.,259, 133, 1970.
19.
CheighJ.S.: Drug administration in renal failure.Am. J. Med.,62, 555, 1977.
20.
AhernM.J., FinkelsteinF.O., AndrioleV.T.: Pharmacokinetics of cefamandole in patients undergoing hemodialysis and peritoneal dialysis.Antimicrob. Ag. Chemother.,10, 457, 1976.
21.
KosmidisJ., StadhakisC., AnyfantisA., DaikosG.K.: Cefuroxin in renal failure: pharmacokinetics and therapeutic results.Proc. R. Soc. Med., 70, suppl.9, 139, 1971.
22.
La GresaG., BiasioliS., ChiaramonteS., FabrisA., FerianiM., PisaniE., RoncoC.: Pharmacokinetics of intravenous and intraperitoneal cefuroxime during peritoneal dialysis.J. Clin. Pharm.,20, 92, 1982.
23.
GlocknerW.M., HofflerU., KindlerJ., PetersG., SieberthH.G.: Elimination kinetics of cefotaxime in patients with renal insufficiency requiring dialysis. In: Abstr. from International Symposium on cefotaxime, Geneve, March 1980.
24.
DanishM., SchultzR., JuskoW.J.: Pharmacokinetics of gentamicin and kanamycin during hemodialysis.Antimicrob. Ag. Chemother.,6, 841, 1974.
25.
GreenbergP.A., SanfordJ.P.: Removal and absorption of antibiotics in patients with renal failure undergoing peritoneal dialysis. Tetracycline, chloramphenicol, kanamycin and colistimethate.Ann. Intern. Med.,66, 465, 1967.
26.
AtkinsR.C., MionC., DespauxE., Van-HaiN., JulienC., MionH.: Peritoneal transfer of kanamycin and its use in peritoneal dialysis.Kidney Int.,3, 391, 1973.
27.
GoodmanL.S., GilmanA.: The pharmacological basis of therapeutics.MacMillan, New York1979.
28.
NeumanR.: Vademecum des antibiotiques et agents chimiotherapiques anti-infectieux.Libraire Maloine S. A. Editeur Paris1979.
29.
RegeurL., ColdingH., JensenH., KampmannJ.P.: Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis.Antimicrob. Ag. Chemother.,11, 214, 1977.
30.
MadhavanT., YaremchukK., LevinN., PohlodD., BurchK., FisherE., CoxF., QuinnE.L.: Effect of renal failure and dialysis on the serum concentration of the aminoglycoside amikacin.Antimicrob. Ag. Chemother.,10, 464, 1976.
31.
OreopoulosD.G.: Chronic peritoneal dialysis in hospital.Contr. Nephrol.,17, 5, 1979.
32.
WinchesterJ.F., GelfandM.C., KnepshieldJ.D., SchreinerG.E.: Dialsis and hemoperfusion of poisons and drugs - update.Trans. ASAIOXXIII, 762, 1977.
HelpernB.A., AxlineS.G., CoplonN.S., BrownD.M.: Clearance of gentamicin during hemodialysis: comparison of four artificial kidney.J. Infect. Dis.,113, 627, 1976.
35.
GaryN.E.: Peritoneal clearance and removal of gentamicin.J. Infect. Dis.,124, 598, 1971.
36.
AronoffG.R., LuftF.C.: Antimicrobial therapy in patients with impaired renal function.Dial. and Transpl.,8, 14, 1979.
37.
ChristopherT.G., BlairA.D., ForreyA.V., CutlerR.: Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide and glucytosine with a tecnique for planning therapy.Pharmacokinetics Biopharmaceutics,4, 441, 1976.
MaherJ.F.: Pharmacologic aspects of renal failure and dialysis.In: Replacement of renal function by dialysis. Edit. By DrukkerWilliam, FrankM. Parsons, and JohnF. Maher, The Hague, Martinus Nijhoff Medical Division, 1983. In press.
40.
LuftF.C., BrannonD.R., StropesL.L., CostelloR.J., SloanR.S., MaxwellD.R.: Pharmacokinetics of netilmicin in patients with renal impairment and in patients on dialysis.Antimicrob. Ag. Chemother.,14, 403, 1978.
MacKayD.N., KayeD.: Serum concentration of colistin in patients with normal and impaired renal function.N. Engl. J. Med.,270, 394, 1964.
43.
CurtisJ.R., EastwoodJ.B.: Colistin sulphomethate sodium administration in the presence of severe renal failure and during hemodialysis and peritoneal dialysis.Brit. Med. J.,1, 484, 1968.
44.
SwichH.M., MaxwellE., CharacheP., LevinS.: Peritoneal dialysis in colistin intoxication: report of a case.J. Ped.,74, 976, 1969.
45.
KuninC.M., ReesS.B., MerrilJ.P., FinlandM.: Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline.J. Clin. Invest.,39, 1487, 1959.
46.
RoseH.D., RothD.A., KochM.L.: Serum tetracycline levels during peritoneal dialysis.Am. J. Med. Sci.250, 66, 1965.
47.
PolecR.B., YehS.D.J., ShilsM.E.: The protective effect of ascorbic acid, isoascorbic acid and mannitol against tetracycline induced nephrotoxicity.J. Pharm. Exp. Ther.,178, 152, 1971.
48.
RottembourgJ., JacqD., SinglasE., N'GuyenM.: Medical management of peritonitis. In: Proc. International Symposium on CAPD.Sd. Excerpta Medica, Parigi1980.
HeldH.: Uber die wirksamkeit der peritonealdialyse bei der behandlung der chininverfiftung.Dtsch. Med. Wschr.,97, 1973, 1972.
51.
SeyffartG.: Poison index. Dialysis and Hemoperfusion in poisonings. By Fresenius Fonudation, Bad Homburg, 1977 (1st suppl., 1979).
52.
BlockE.R., BennetJ.E., LevottiL.G., KleinW.J., MacGregorR.R., HendersonL.: Flucytosine and aphotericin B: hemodialysis effects on the plasma concentration and clearance.Ann. Intern. Med.,80, 613, 1974.
53.
RevertL., LopezJ., PonsJ., OlayT.: Fosfomycin in patients subjected to periodic hemodialysis.Chemotherapy, 23, suppl.1, 204, 1977.
54.
DaletF., BadeG., RodaM.: Pharmacokinetic of fosfomycin during hemodialysis.Chemotherapy, 23, suppl.1, 210, 1977.
55.
FurmanK.I., CoornhofH.J., Kilroe-SmithT.A., LandlessR., RobinsonR.G.: Peritoneal transfer of thiamphenicol during peritoneal dialysis.Antimicrob. Ag. Chemother.,9, 557, 1976.
56.
DumeT., WagnerC., WerzelsE.: Blood levels and elimination of ethambutol dihydrochloride in peritoneal dialysis. Current problems of dialysis procedures and renal failure.Friedberg1971.
57.
CoccoA.E., PazourekL.J.: Acute isoniazid intoxication. Management by peritoneal dialysis. New Engl.J. Med.,269, 852, 1968.
MaherJ.F., SchreinerG.E., Marc-AureleJ.: Methodologic problems associated with in vitro measurements of dialysance.Trans. ASAIOV, 120, 1959.
60.
MeyrierA. e coll.: Impiego dell'ac. pipemidico come antibiotico extra-urinario in soggetti con insufficienza renale ed in emodializzati. Cinetica delle concentrazioni ematiche ed urinarie.Nouv. Press. Med.,7, 117, 1978.
61.
GoldbaumL.R., SmithP.K.: The interaction of barbiturates with serum albumin and its possible relation to their disposition and pharmacological actions.J. Pharm. Exp. Ther.,111, 197, 1954.
62.
RosenbaumJ.L., KramerL.S., RajaR.: Resin hemoperfusion for acute drug intoxication.Arch. Intern. Med.,136, 263, 1976.
63.
ChangT.M.S., MalaveN.: The development and first clinical use of semipermeable microcapsules (artificial cells) as a compact artificial kidney.Trans ASAIOXVI, 141, 1970.
64.
SetterJ.C., FreemanR.B., MaherJ.F., SchreinerG.E.: Factors influencing the dialysis of barbiturates.Trans. ASAIOX, 340, 1964.
65.
EdwardsK.D.J.: Methods of extrarenal removal of drugs including the use of dialysis and ion exchange resins in barbiturate poisoning.Postgrad. Bull.,20, 89, 1964.
66.
QuellhorstE., SchelerF.: Die behandlung von vergiftungen mittels ultrafiltrations peritoneal dialyse. In: FreyR., HalmagyiM., LangK., OettelP.: Vergiftungen (Springer, Berlin), 1970.
67.
BermanL.B., VogelsangP.: Removal rates for barbiturates using two types of peritoneal dialysis.N. Engl. J. Med., 270, 77, 1984.
68.
NahasG.G., GirouxJ.J., GjessingJ., VeroskyM., MarkL.C.: The use of THAM in peritoneal dialysis.Trans. ASAIOX, 345, 1964.
69.
BloomerH.A.: Limited usefulness of alkaline diuresis, peritoneal dialysis in pentobarbital intoxication. New Engl.J. Med.,272, 1309, 1965.
70.
El-BassiouniE.A., MattocksA.M.: Acceleration of peritoneal dialysis with minimal N-myristyl-beta-aminopropionate.J. Pharm. Sci.,62, 1314, 1973.
71.
KuddaR.M., El-BassiouniE.A., MattocksA.M.: Accelerated peritoneal dialysis of barbiturates, diphenylhydantoin, and salicylate.J. Pharm. Sci.,60, 1065, 1971.
72.
RuedyG., CherneckiW.: The use of a binding agent, polyvinylpyrrolidone, in the treatment of experimental barbiturate intoxication in rabbits.Can. J. Physiol. Pharm.,46, 829, 1968.
73.
ZileliM., TeletarF., DenizS., literE., AdalarN.: Pseudohyperosmolar nonketoacidotic coma due to oxazepam intoxication.Clin. Toxicol.,5, 337, 1972.
MaddockR.K., BlommerH.A.: Meprobamate overdosage. Evaluation of severity and methods of treatment.JAMA,201, 999, 1967.
83.
MoutonD.E., CohenR.G.: Meprobamate poisoning. Successful treatment with peritoneal dialysis.Am. J. Med. Sci.,253, 706, 1967.
84.
WiddopB., MeddR.K., BraithwaiteR.A., RessA.J., GouldingR.: Experimental drug intoxication: treatment with charcoal hemoperfusion.Arch. Toxikol.,34, 27, 1975.
85.
MandelbaumJ.M., SimonN.M.: Severe methyprylon intoxication treated by hemodialysis.JAMA,216, 139, 1971.
86.
KnepshieldJ.H., SchreinerG.E., LowenthalD.T., GelfandM.C.: Dialysis of poison and drugs — annual review.Trans. ASAIOXIX, 590, 1973.
87.
ChangT.M.S., CoffeyJ.F., ListerC., TaroyE., StarkA.: Methaqualone, methyprylon and glutethimide clearance by the ACAC microcapsule artificial kidney: in vitro and in patients with acute intoxication.Trans. ASAIOXIX, 87, 1973.
88.
ProudfootA.T., NobleJ., NimmoJ., BrownS.S., CameronJ.C.: Peritoneal dialysis and hemodialysis in methaqualone (Mandrax*) poisoning.Scot. Med. J.,13, 232, 1968.
89.
SchmittG.W., MaherJ.F., SchreinerG.E.: Ethacrynic acid enhanced bromuresis: a comparison with peritoneal and hemodialysis.J. Lab. Clin. Med.,68, 913, 1966.
90.
WronskiR., ButteW., VollnbergW.: In vivo und in vitro untersuchungen zur bromureid entgiftung durch forcierte diurese, hamedialyse und hamoperfusion (A. klinischer teil). Intensiv-medizin 13, suppl.zu,13, 62, 1976.
VersaciA.A., NakamotoS., KolffW.J.: Phenelzine intoxication. Report of a case treated by hemodialysis.Ohio St. Med. J., 60, 770, 1964.
98.
LipkinD.L., HushnickT.: Pargyline hydrochloride poisoning in a child.JAMA,201, 135, 1967.
99.
ReidebergM.M., Odar-CederlofI., Von BahrC., BorgaO., SjoqvistF.: Protein bindings of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.N. Engl. J. Med.285, 264, 1971.
100.
LetteriJ., MellkH., LouisS., DuranteP., GlaszcoA.: Diphenylhydantoin metabolism in uremia.N. Engl. J. Med.,285, 648, 1971.
Villalba-PimentelL., EpsteinL.M., SellersE.M., ForsterJ.R., BennionL.J., NadlerL.B., BaueE.W., Koch-WeserJ.: Survival after massive procainamide ingestion.Am. J. Cardiol.,32, 727, 1973.
111.
HiltonD.D.: Pharmacokinetics of metoprolol in normotensive patients with en d stage renal failure on regular dialysis.Report of an Int. Clin. Symp.: Modern aspects of beta blockers therapy, Ed. by BirdwoodG.F.B., WinkC.A.S., 157, Geigy Pharmaceuticals Macclesfield.
112.
YehB.K., DaytonP.G., WatersW.C.: Removal of alpha-methyldopa (Aldomet*) in man by dialysis.Proc. Soc. Exp. Biol. Med.,135, 840, 1970.
113.
SellersE.M., Koch-WeserJ.: Protein binding and vascular activity of diazoxide.New Engl.,281, 1141, 1969.
114.
WolfsonM.: Pharmacologic management of adult patients on chronic hemodialysis.Dial. and Transpl.,8, 52, 1979.
115.
SeilerK.U., AlbrechtH.U., NeidermayerW., WassermannO.: Pharmacokinetics of atenolol in dialysis patients. Atenolol and renal function: Royal Society of Medicine International Congress and Symposium Series n° 19, publ. by Academic Press Inc. (London) and the Royal Society of Medicine.
116.
SchreinerG.E., MaherJ.F., Marc-AureleJ.: The dialysance of exogenous poisons and some common metabolites in the twin-coil artificial kidney.J. Clin. Invest.,38, 1040, 1959.
117.
GaultierM., BismuthC., KanferA.: Epuration extrarenal en dehors de I'insuffisance renale.Rev. Prat. Paris,19, 1359, 1969.
118.
EtteldorfJ.N., DobbinsW.T., SummittR.L., RainwaterW.T., FischerR.L.: Intermittent peritoneal dialysis using 5% albumin in the treatment of salicylate intoxication in children.J. Pediat.,58, 226, 1961.
119.
MattocksA.M.: Accelerated removal of salicylate by additives in peritoneal dialysis fluid.J. Pharm. Sci.,58, 595, 1969.
GallettiP.M., PasqualinoA., GeeringR.G.: Hemodialysis in cancer chemotherapy.Trans. ASAIOXII, 20, 1966.
125.
PasqualinoA., Pavone MacalusoM., MadoniaS., GallettiP.M.: Diuresi forzata, dialisi peritoneale, emodialisi centrale ed emodialisi periferica nella protezione degli effetti tossici del 5-Fluorouracile.Minerva Med.,80, 687, 1969.
AlthoffP.H., FassbinderW., NeubauerM., KochK.M., SchofflingK.: Hamodialyse bei der behandlung der biguanid induzierten lactacidose.Dtsch. Med. Wschr.,103, 61, 1978.
128.
HayatJ.C.: The treatment of lactic acidosis in the diabetic patient by peritoneal dialysis using sodium acetate. A report of two cases.Diabetolofia,10, 485, 1974.
129.
FlynnC.T., HibbardJ., DohrmanB.: Advantages of continuous ambulatory peritoneal dialysis to the diabetic with renal failure.Proc. E.D.T.A.,16, 184, 1979.
130.
CrossleyK., KjellstrandC.M.: Intraperitoneal insulin for control of blood sngar in diabetic patients during peritoneal dialysis.Br. Med. J.,1, 269, 1971.
131.
LevyG., GibsonT.P., WhitmanW., ProcknalJ.: Hemodialysis clearance of theophylline.JAMA237, 1466, 1977.
LimP., ChirB., DongS., KhooO.T.: Intracellular magnesium depletion in chronic renal failure. New Engl.J. Med.,280, 981, 1969.
139.
GoodwinF.J., VinceF.P.: Hypermagnesaemic encephalopathy due to antacid ingestion occurrinè during regular dialysis treatment.Br. J. Urol.,42, 586, 1970.
140.
WallaceH.E., NeumayerF., GutchC.F.: Amphetamine poisoning and peritoneal dialysis: a case report.Am. J. Dis. Child,108, 657, 1964.
141.
EspelinD.E., DoneA.K.: Amphetamine poisoning effectiveness of chlorpromazine. New Engl.J. Med.,278, 1361, 1968.
142.
McGonigueR.J.S., WilliamsL.C., AmphlettG.E., EnglandR.J., ParsonsV.: Ranitidine clearance in patients with renal impairment.Scandinavian Journal of gastroenterology. Vol. 17, Supp. 78A435, 1982.
143.
JonesE.M., WilliamsB.: Two cases of ergotamine poisoning in infants.Br. Med. J.,1, 466, 1966.
144.
GuttF.W., ScroggieJ.C.: Eucalpyptus oil poisoning treated by dialysis and mannitol infusion.Austr. Ann., Med.14, 238, 1965.
145.
AviramA., PfauA., CsaczkesJ.W., UllmannT.D.: Hyperosmolality with hyponatremia, caused by inappropriate administration of mannitol.Am. J. Med.,42, 648, 1967.